The Government is proposing new regulations that will require manufacturers, wholesalers and pharmacies to provide it with information about the products they supply and the costs of doing business.

The information will be used to determine ‘fair’ reimbursement prices for generics and specials, and help ensure the availability and value-for-money of medicines, says the Department of Health.

The draft regulations give the Government the power to control the price of medicines in certain circumstances, and will provide the DH with a stronger legal basis for enforcing the provision of information in areas like the pharmacy margins survey.

The proposals, which extend existing voluntary schemes, require:

  • Manufacturers, importers and wholesalers to provide quarterly information about sales and purchases of generics and specials products
  • All those involved in the supply chain, including pharmacies, to record, keep and provide on request information related to sales and purchases of medicines, medical supplies and other related products
  • Manufacturers and importers to tell Government about any discontinuation and supply shortages.

A consultation on the draft regulations, made under the Health Service Medical Supplies (Costs) Act 2017, runs until November 14.

Originally Published by Pharmacy Magazine

Recommended

Interview: PSNC's Simon Dukes

Simon Dukes has taken on the toughest job in UK pharmacy and he’s going to need all his experience to sort out the...

Pharmacy organisations to meet with MPs

Representatives of the community pharmacy profession are hosting a Parliamentary briefing to highlight pharmacy's role i...




This website is for healthcare professionals only. By clicking "Accept" to hide this message or by clicking into any content on this website, you confirm you are a healthcare professional, consent to accepting cookies in accordance with our Cookie Policy and agree to British Pharmaceutical Students' Association’s Terms of Use and Privacy Policy.